Search research articles
Contact Us
Filters
Showing results (141-150 of 170) with videos related to
Page
of 17
Sort By:
Cancer Medicine
|
January 19, 2021
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Chun Loo Gan, Shaan Dudani, J Connor Wells, et al.
European Urology
|
April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
Alexander D Sherry, Van To, Criselle D'souza, et al.
Journal of Geriatric Oncology
|
March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis
Daniel V Araujo, J Connor Wells, Aaron R Hansen, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Jayesh Desai, Hui Gan, Catherine Barrow, et al.
Cancer Medicine
|
November 13, 2019
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
Ben Tran, Jose M Ruiz-Morales, Enrique Gonzalez-Billalabeitia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
European Urology
|
May 27, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
Cameron Herberts, Andrew J Murtha, Simon Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
Angelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Science Translational Medicine
|
July 8, 2016
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 170) with videos related to
Sort By:
Page
of 17
Cancer Medicine
|
January 19, 2021
Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Chun Loo Gan, Shaan Dudani, J Connor Wells, et al.
European Urology
|
April 28, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
Alexander D Sherry, Van To, Criselle D'souza, et al.
Journal of Geriatric Oncology
|
March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis
Daniel V Araujo, J Connor Wells, Aaron R Hansen, et al.
JAMA Oncology
|
September 17, 2020
Efficacy and Safety of nab-Paclitaxel vs Paclitaxel on Survival in Patients With Platinum-Refractory Metastatic Urothelial Cancer: The Canadian Cancer Trials Group BL.12 Randomized Clinical Trial
Srikala S Sridhar, Normand Blais, Ben Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 18, 2020
Phase I, Open-Label, Dose-Escalation/Dose-Expansion Study of Lifirafenib (BGB-283), an RAF Family Kinase Inhibitor, in Patients With Solid Tumors
Jayesh Desai, Hui Gan, Catherine Barrow, et al.
Cancer Medicine
|
November 13, 2019
Large retroperitoneal lymphadenopathy and increased risk of venous thromboembolism in patients receiving first-line chemotherapy for metastatic germ cell tumors: A study by the global germ cell cancer group (G3)
Ben Tran, Jose M Ruiz-Morales, Enrique Gonzalez-Billalabeitia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 4, 2020
Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)
Christoph Seidel, Gedske Daugaard, Tim Nestler, et al.
European Urology
|
May 27, 2020
Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
Cameron Herberts, Andrew J Murtha, Simon Fu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 24, 2022
Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
Angelika Terbuch, Florian Posch, Thomas Bauernhofer, et al.
Science Translational Medicine
|
July 8, 2016
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, et al.
Page
of 17